Nucryst Pharmaceuticals Corp.

Company Overview

Nucryst Pharmaceuticals Corp. develops, manufactures and commercializes medical products that fight infection and inflammation using its patented atomically disordered nanocrystalline silver technology. Nucryst's business strategy is to maximize return on investment by partnering with established leaders in pharmaceutical manufacturing for effective market penetration of its businesses through out-licensing or co-development/co-marketing agreements.

Nucryst received a patent earlier this year for use of its proprietary nanocrystalline silver in the treatment of acne. The company already holds parents related to use of its silver to treat inflammatory skin conditions such as atopic dermatitis and hyperproliferative skin disorders such as psoriasis. Nucryst also is researching potential pharmaceutical products containing its silver for use in treating gastrointestinal disorders, particularly inflammatory bowel disease, which includes ulcerative colitis and Crohn’s disease.

Quick Facts
Nucryst Pharmaceuticals Corp.
50 Audubon Road, Suite B
Wakefield, MA 01880

Featured Solutions

• Suppressive effects of topical nanocrystalline silver in allergic contact ... by Nucryst Pharmaceuticals Corp.
  This white paper by Nucryst Pharmaceuticals suggests that nanocrystalline silver cream showed significant inhibitory activity against contact dermatitis in mice, similar to high potency steroid and tacrolimus.